Further literature review revealed that LHX9 is a common transcription factor in the LHX family, which can participate in the progression of osteosarcoma, glioma, and ovarian cancer, and is closely associated with the glycolytic reprogramming of glioma and ovarian cancer [13, 15, 20]. The gene discussed is RAB2A; the disease is glioma.